• Mashup Score: 0

    The FDA is considering an application for vibegron for the treatment of patients with OAB with symptoms of urge urinary incontinence, urgency, and urinary frequency.

    Tweet Tweets with this article
    • Vibegron sustains clinical benefit in patients with overactive bladder in posthoc analysis. https://t.co/B1TfWRzCSY #OAB #urology #urologist #FDA #overactivebladder @TuftsMedSchool #ICSMeeting

  • Mashup Score: 2
    Abstracts - 4 year(s) ago

    Submit Now!

    Tweet Tweets with this article
    • RT @icsoffice: Now Open -ICS 2020 Abstract Submission! Submit your abstract by 1st April 2020 https://t.co/CV8bpKez2h #ICSMeeting @ghoniem_…

  • Mashup Score: 0
    Abstracts - 4 year(s) ago

    Submit Now!

    Tweet Tweets with this article
    • RT @icsoffice: ICS Scientific Chair, Laurence Stewart, provides his top tips for abstract submission! https://t.co/MkOtIIrNXH #ICSMeeting h…

  • Mashup Score: 1

    ICS News story about Why submit your work to ICS 2020? Hear from ICS leaders

    Tweet Tweets with this article
    • RT @icsoffice: Why submit your work to ICS 2020? Hear from ICS leaders https://t.co/fjC7SlenXV #ICSMeeting @ghoniem_gamal https://t.co/TNQJ…